Despite certain limitations, this study provides comprehensive evidence on plasma-detected PIK3CA mutations in Vietnamese BC and supports the integration of liquid biopsy into clinical management for mutation profiling, risk stratification, and treatment selection. This evidence concerns the gene PIK3CA and breast cancer.